FK506 in the treatment of inflammatory skin disease: Promises and perspectives

Günter Michel, L. Kemény, Bernhard Homey, Thomas Ruzicka

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

The immunosuppressive macrolide drug FK506 is currently gaining increasing importance in dermatopharmacology. Here, Gunter Michel and colleagues summarize the current state of research into the molecular mechanisms responsible for the functional modulation of cell types other than T cells, particularly epidermal cells, by this drug.

Original languageEnglish
Pages (from-to)106-108
Number of pages3
JournalImmunology Today
Volume17
Issue number3
DOIs
Publication statusPublished - Mar 1996

Fingerprint

Tacrolimus
Skin Diseases
Macrolides
Immunosuppressive Agents
Pharmaceutical Preparations
T-Lymphocytes
Research

ASJC Scopus subject areas

  • Immunology

Cite this

FK506 in the treatment of inflammatory skin disease : Promises and perspectives. / Michel, Günter; Kemény, L.; Homey, Bernhard; Ruzicka, Thomas.

In: Immunology Today, Vol. 17, No. 3, 03.1996, p. 106-108.

Research output: Contribution to journalArticle

Michel, Günter ; Kemény, L. ; Homey, Bernhard ; Ruzicka, Thomas. / FK506 in the treatment of inflammatory skin disease : Promises and perspectives. In: Immunology Today. 1996 ; Vol. 17, No. 3. pp. 106-108.
@article{f0ebf8e9a64c4ff7865ec0db97f1b906,
title = "FK506 in the treatment of inflammatory skin disease: Promises and perspectives",
abstract = "The immunosuppressive macrolide drug FK506 is currently gaining increasing importance in dermatopharmacology. Here, Gunter Michel and colleagues summarize the current state of research into the molecular mechanisms responsible for the functional modulation of cell types other than T cells, particularly epidermal cells, by this drug.",
author = "G{\"u}nter Michel and L. Kem{\'e}ny and Bernhard Homey and Thomas Ruzicka",
year = "1996",
month = "3",
doi = "10.1016/0167-5699(96)80599-8",
language = "English",
volume = "17",
pages = "106--108",
journal = "Trends in Immunology",
issn = "1471-4906",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - FK506 in the treatment of inflammatory skin disease

T2 - Promises and perspectives

AU - Michel, Günter

AU - Kemény, L.

AU - Homey, Bernhard

AU - Ruzicka, Thomas

PY - 1996/3

Y1 - 1996/3

N2 - The immunosuppressive macrolide drug FK506 is currently gaining increasing importance in dermatopharmacology. Here, Gunter Michel and colleagues summarize the current state of research into the molecular mechanisms responsible for the functional modulation of cell types other than T cells, particularly epidermal cells, by this drug.

AB - The immunosuppressive macrolide drug FK506 is currently gaining increasing importance in dermatopharmacology. Here, Gunter Michel and colleagues summarize the current state of research into the molecular mechanisms responsible for the functional modulation of cell types other than T cells, particularly epidermal cells, by this drug.

UR - http://www.scopus.com/inward/record.url?scp=0343882000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0343882000&partnerID=8YFLogxK

U2 - 10.1016/0167-5699(96)80599-8

DO - 10.1016/0167-5699(96)80599-8

M3 - Article

C2 - 8820265

AN - SCOPUS:0343882000

VL - 17

SP - 106

EP - 108

JO - Trends in Immunology

JF - Trends in Immunology

SN - 1471-4906

IS - 3

ER -